Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGDR2 | Q9Y5Y4 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HTR1A | P08908 | 4/20 | 0.46 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.46 |
| ▸ | HTR1D | P28221 | 2/20 | 0.45 |
| ▸ | HTR1B | P28222 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.44 |
| ▸ | HTR2C | P28335 | 2/20 | 0.44 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.44 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | DRD1 | P21728 | 1/20 | 0.44 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42935 | 1.00 | PTGDR2 (0.58) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| SCHEMBL5159996 | 1.00 | PTGDR2 (0.58) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| SCHEMBL2352942 | 0.98 | PTGDR2 (0.56) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| SCHEMBL9997758 | 0.91 | PTGDR2 (0.55) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| Isopropylbenzene SCHEMBL11315929 | 0.86 | PTGDR2 (0.50) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| SCHEMBL2399633 | 0.83 | PTGDR2 (0.57) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| SCHEMBL3679820 | 0.83 | PTGDR2 (0.46) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| SCHEMBL7180838 | 0.82 | PTGDR2 (0.47) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| SCHEMBL7598684 | 0.81 | HTR1A (0.70) | PTGDR2MEN1KMT2AHTR1ASLC6A2 | |
| SCHEMBL4736528 | 0.80 | HTR2C (0.68) | PTGDR2MEN1KMT2AHTR1DHTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2352715-A1 | PROCESS FOR PRODUCING PHENOL | Exxonmobil Chemical Company (US) | 2011-08-10 | — | — | EP | claimed |
| US-20110190546-A1 | Process For Producing Phenol | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-08-04 | — | — | US | claimed |
| WO-2010042261-A1 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL COMPANY (US) | 2010-04-15 | — | — | WO | claimed |
| US-9249078-B2 | Mixed metal oxide catalysts and use thereof | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150148567-A1 | MIXED METAL OXIDE CATALYSTS AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2015-05-28 | — | — | US | disclosed |
| US-8445730-B2 | Process for producing phenol | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-05-21 | — | — | US | disclosed |
| WO-2013052217-A2 | MIXED METAL OXIDE CATALYSTS AND USE THEREOF | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2013-04-11 | — | — | WO | disclosed |
| EP-2352715-A1 | PROCESS FOR PRODUCING PHENOL | Exxonmobil Chemical Company (US) | 2011-08-10 | — | — | EP | disclosed |
| US-20110190546-A1 | Process For Producing Phenol | EXXONMOBIL CHEMICAL PATENTS INC. | 2011-08-04 | — | — | US | disclosed |
| WO-2010042261-A1 | PROCESS FOR PRODUCING PHENOL | EXXONMOBIL CHEMICAL COMPANY (US) | 2010-04-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150148567-A1 | MIXED METAL OXIDE CATALYSTS AND USE THEREOF | SOD1, SOD3, LPO | PTGDR2 4318/4885MEN1 2860/4885KMT2A 3096/4885 |
| US-20110190546-A1 | Process For Producing Phenol | CYP1A1, PAH, MYB | PTGDR2 661/4885MEN1 3659/4885KMT2A 2997/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.